RxDoctor Payments Data

Sheldine Edwards

Family · Charlotte, NCNPI 1952603441

Payments from drug & device makers

$3,540in general payments, 2019–2025

Across 174 payments — averaging $20.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$540
  • AstraZeneca$424
  • Gilead$355
  • Lilly USA, LLC$298
  • Pfizer$287
  • Novo Nordisk$262
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$3,526100%
  • Entertainment$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,540 in reported general payments places this provider in the 90th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol15$16,624
EliquisApixaban14$14,185
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen29$775
Atorvastatin Calcium87$598
Albuterol Sulfate HfaAlbuterol Sulfate22$545
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen20$451
Gabapentin27$417
Amlodipine Besylate59$382
Losartan Potassium36$350
Clonazepam27$289
Omeprazole23$270
Lisinopril47$256
Fluoxetine Hcl20$211
Pantoprazole Sodium13$208
Metformin Hcl ErMetformin Hcl20$185

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$424$16,62415 claims
PfizerEliquis$287$14,18514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,522 family providers in North Carolina.

Other family in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →